Cite
HARVARD Citation
Franken, M. et al. (2017). Cost-effectiveness of capecitabine and bevacizumab maintenance treatment after first-line induction treatment in metastatic colorectal cancer. European journal of cancer. pp. 204-212. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Franken, M. et al. (2017). Cost-effectiveness of capecitabine and bevacizumab maintenance treatment after first-line induction treatment in metastatic colorectal cancer. European journal of cancer. pp. 204-212. [Online].